Advertisement
Screener

Verastem, Inc. (VSTM) ROA

Verastem, Inc. ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Verastem, Inc. roa for the quarter ending 2026-06-30 was -98.15%, a change of -13.29% year-over-year.
  • Verastem, Inc. roa for the quarter ending 2026-03-31 was -85.14%, a change of 27.90% year-over-year.
  • Verastem, Inc. roa for the quarter ending 2025-12-31 was -85.00%, a change of 43.66% year-over-year.
  • Verastem, Inc. roa for the quarter ending 2025-09-30 was -136.33%, a change of -62.38% year-over-year.
  • Verastem, Inc. roa for fiscal 2025 was -85.00%, a change of 43.66% from fiscal 2024.
  • Verastem, Inc. roa for fiscal 2024 was -128.66%, a change of -70.30% from fiscal 2023.
  • Verastem, Inc. roa for fiscal 2023 was -58.35%, a change of 19.30% from fiscal 2022.
  • Verastem, Inc. roa for fiscal 2022 was -77.66%, a change of -12.13% from fiscal 2021.
Available history
2011-12-31 to 2026-06-30
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-30-98.15%-$202.7M-$34.67M$206.51M
2026-03-31-85.14%-$193.96M-$36.59M$227.81M
2025-12-31-85.00%-$209.47M-$32.92M$246.44M
2025-09-30-136.33%-$241.11M-$98.52M$176.85M
2025-06-30-84.86%-$166.56M-$25.93M$196.26M
2025-03-31-113.04%-$148.88M-$52.10M$131.7M
2024-12-31-128.66%-$130.64M-$64.55M$101.54M
2024-09-30-73.95%-$93.45M-$23.97M$126.38M
2024-06-30-84.63%-$89.49M-$8.26M$105.75M
2024-03-31-85.41%-$105.52M-$33.86M$123.54M
2023-12-31-58.35%-$87.37M-$27.37M$149.72M
2023-09-30-43.60%-$76.81M-$20.00M$176.15M
2023-06-30-39.06%-$74.89M-$24.28M$191.76M
2023-03-31-60.03%-$72.56M-$15.71M$120.88M
2022-12-31-77.66%-$73.81M-$16.81M$95.05M
2022-09-30-66.15%-$73.49M-$18.09M$111.1M
2022-06-30-77.86%-$78.18M-$21.95M$100.41M
2022-03-31-62.96%-$73.13M-$16.96M$116.15M
2021-12-31-65.52%-$71.2M-$16.48M$108.66M
2021-09-30-66.67%-$74.58M-$22.79M$111.88M
2021-06-30-31.20%-$38.66M-$16.90M$123.89M
2021-03-31-32.70%-$44.77M-$15.03M$136.9M
2020-12-31-43.88%-$67.73M-$19.86M$154.35M
2020-09-30-39.78%-$86.64M$13.14M$217.77M
2020-06-30-65.44%-$129.91M-$23.01M$198.53M
2020-03-31-71.63%-$149.1M-$37.99M$208.15M
2019-12-31-102.87%-$149.21M-$38.77M$145.05M
2019-09-30-63.23%-$121.78M-$30.14M$192.6M
2019-06-30-51.85%-$113.31M-$42.19M$218.54M
2019-03-31-36.77%-$89.49M-$38.10M$243.37M
2018-12-31-26.13%-$72.43M-$11.35M$277.24M
2018-09-30-43.31%-$79.32M-$21.67M$183.16M
2018-06-30-46.71%-$80.78M-$18.37M$172.92M
2018-03-31-110.87%-$75.85M-$21.05M$68.41M
2017-12-31-75.51%-$67.8M-$18.23M$89.79M
2017-09-30-96.96%-$61.22M-$23.13M$63.14M
2017-06-30-74.42%-$46.02M-$13.44M$61.84M
2017-03-31-53.97%-$41.15M-$13.01M$76.25M
2016-12-31-43.57%-$36.44M-$11.65M$83.63M
2016-09-30-41.16%-$36.65M-$7.92M$89.04M
2016-06-30-46.29%-$44.17M-$8.57M$95.42M
2016-03-31-49.70%-$50.98M-$8.29M$102.56M
2015-12-31-51.17%-$57.87M-$11.86M$113.09M
2015-09-30-48.48%-$59.95M-$15.45M$123.67M
2015-06-30-42.62%-$57.84M-$15.38M$135.7M
2015-03-31-39.07%-$55.48M-$15.18M$142M
2014-12-31-54.10%-$53.37M-$13.95M$98.65M
2014-09-30-51.84%-$50.74M-$13.33M$97.88M
2014-06-30-44.72%-$48M-$13.02M$107.34M
2014-03-31-39.08%-$45.23M-$13.06M$115.73M
2013-12-31-32.89%-$41.2M-$11.32M$125.26M
2013-09-30-28.54%-$37.8M-$10.59M$132.43M
2013-06-30-46.99%-$37.58M-$10.25M$79.96M
2013-03-31-39.60%-$34.15M-$9.04M$86.24M
2012-12-31-34.42%-$31.98M-$7.92M$92.92M
2012-09-30-30.42%-$30.07M-$10.37M$98.83M
2012-06-30-22.48%-$23.75M-$6.83M$105.66M
2012-03-31-17.53%-$19.41M-$6.87M$110.71M
2011-12-31-23.18%-$13.68M-$6.00M$59.04M

Annual ROA

DateROANet income 12 monthTotal assets
2025-12-31-85.00%-$209.47M$246.44M
2024-12-31-128.66%-$130.64M$101.54M
2023-12-31-58.35%-$87.37M$149.72M
2022-12-31-77.66%-$73.81M$95.05M
2021-12-31-65.52%-$71.2M$108.66M
2020-12-31-43.88%-$67.73M$154.35M
2019-12-31-102.87%-$149.21M$145.05M
2018-12-31-26.13%-$72.43M$277.24M
2017-12-31-75.51%-$67.8M$89.79M
2016-12-31-43.57%-$36.44M$83.63M
2015-12-31-51.17%-$57.87M$113.09M
2014-12-31-54.10%-$53.37M$98.65M
2013-12-31-32.89%-$41.2M$125.26M
2012-12-31-34.42%-$31.98M$92.92M
2011-12-31-23.18%-$13.68M$59.04M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
IRONWOOD PHARMACEUTICALS INC (IRWD)United States$0.694B5.37
Climb Bio, Inc. (CLYM)United States$0.683B-13.03
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
Faeth Therapeutics, Inc. (FTH)United States$0.750B
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
Wave Life Sciences, Inc. (WVE)$0.780B-5.56